Not necessarily: We have three oral agents, each as potent, or more potent, than the injectables, but each has it's own risk and adverse effect profiles. The two most potent meds on the market are tysabri, (natalizumab) followed by gilenya. Tysabri (natalizumab) is a once monthly infusion, and gilenya, oral once daily.
Answered 6/18/2014
4.2k views
5 doctors weighed in across 3 answers
5 doctors weighed in across 2 answers
4 doctors weighed in across 2 answers
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question